Our Partners
Future FinTech Group (FTFT)
FTTFT International Securities is dedicated to building a globally leading financial services platform, providing clients with comprehensive one-stop financial services and solutions. Established in 2010 and affiliated with the FTTFT Financial Technology Group (NASDAQ: FTFT), the company is a licensed corporation approved by the Hong Kong Securities and Futures Commission (SFC Central No.: ATR516), holding licenses for Type 1, Type 2, and Type 4 regulated activities.
With over 20 years of experience, FTTFT International Securities has successfully guided more than 60 companies to list overseas across 26 countries. The team comprises seasoned professionals from top-tier firms like UBS, Mitsubishi, Geely, and SPDB, with deep expertise in finance, investment banking, and corporate governance.
Global Presence
Headquartered in Hong Kong, FTTFT operates branches in New York, London, Dubai, Shenzhen, Beijing, and Xi'an, ensuring seamless support for clients worldwide.
Beijing Tianyi Yuanfang Biotechnology
Beijing Tianyi Yuanfang Biotechnology Co., Ltd. (referred to as "Tianyi Yuanfang Biotech") was established in 2020. Driven by cell biotechnology, the company focuses on the development and industrial application of bioactive ingredients such as cell active extracts. It is dedicated to building a cell-integrated industrial ecosystem, continually pursuing its mission of "Cell Technology Serving Human Health and Beauty." Highlights:
-
20 years of industry experience, resulting in 11 invention patents, 1 PCT patent, 4 pending patents, and 20+ SCI papers.
-
60+ proprietary technologies (trade secrets)
-
10+ domestic and international invention patents
-
10+ trademark registrations
Biotech & Biomedicine (Shenyang) Group
Developer of life science innovations designed for advancing new technologies, drugs, and products in the biomedical field in particular diagnostics both clinical and molecular. The company focuses on building an integrated academic, research, production, and application ecosystem, providing a comprehensive value chain for life sciences R&D and industrialization.